胃腸藥錠

Pays: Taïwan

Langue: chinois

Source: 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

Ingrédients actifs:

DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA);;DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA);;MAGNESIUM ALUMINUM METASILICATE (NEUSILIN);;SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE);;CALCIUM CARBONATE;;SCOPOLIA EXTRACT;;L-MENTHOL ;;COPTIS POWDER;;PHELLODENDRON BARK POWDER (EQ TO POWDERED PHELLODENDRON BARK);;CINNAMON POWDER (CINNAMON CORTEX POWDER);;FENNEL POWDER (FOENICULI POWDER);;CLOVE POWDER;;ZINGER POWDER;;ZANTHOXYLUM POWDER;;GLYCYRRHIZA RADIX POWDER

Disponible depuis:

中國化學製藥股份有限公司 台北巿襄陽路２３號 (03088802)

forme pharmaceutique:

錠劑

Composition:

SCOPOLIA EXTRACT (1208004502) 3.33MG; SODIUM BICARBONATE ( EQ TO SODIUM HYDROGEN CARBONATE) (4008000700) 75MG; DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA) (4400002100) 33.33MG; DIASTASE ASPERGILLUS ORYZAE(DIASTASE TAKA) (4400002100) (N) 8.33MG; MAGNESIUM ALUMINUM METASILICATE (NEUSILIN) (5604000501) 100MG; CALCIUM CARBONATE (5604001200) (PPT) 50MG; CINNAMON POWDER (CINNAMON CORTEX POWDER) (5610000103) 24.83MG; FENNEL POWDER (FOENICULI POWDER) (5610000301) 6.66MG; COPTIS POWDER (5612003802) 5MG; PHELLODENDRON BARK POWDER (EQ TO POWDERED PHELLODENDRON BARK) (5640001512) 11.66MG; CLOVE POWDER (7200000301) 3.33MG; L-MENTHOL (8408000302) 0.66MG; GLYCYRRHIZA RADIX POWDER (9200004411) 39.33MG; ZINGER POWDER (9200015001) 8.16MG; ZANTHOXYLUM POWDER (9200016101) 0.33MG

Unités en paquet:

瓶裝

classe:

製　劑

Type d'ordonnance:

須經醫師指示使用

Fabriqué par:

SANKYO CO. LTD. 173,KOUNOUCHI,NAKAHARA-KAMIJU KU,HIRATSUKA-SHI,KANAGAWA JAPAN. JP

indications thérapeutiques:

食慾不振、胃酸過多症、腹部膨脹、消化不良

Descriptif du produit:

註銷日期: 1988/02/12; 註銷理由: 主成分變更; 有效日期: 1987/06/30; 英文品名: GASTROINTESTINAL MEDICINE TABLETS "SANKYO"

Statut de autorisation:

已註銷

Date de l'autorisation:

1982-06-30